How long healed diabetic foot ulcers stay closed after CAMPX treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective long-term follow-up of participants from the CAMPX randomized, controlled trial who achieved complete wound closure at the 12-week endpoint. After signing consent, participants will receive instruction and written guidance on using the BlueDrop OneStep Foot Scanner for home photographic and thermal imaging. Data will be collected at roughly 3, 6, 9, and 12 months, with questionnaires used for participants unable to perform scanner measurements. The primary focus is durability of closure as documented by images and thermal scans over the 12-month follow-up period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The potential subject must have participated in the CAMPX trial and achieved complete closure by the 12-week endpoint.

Exclusion Criteria:

* The potential subject did not participate in the CAMPX trial.
* The potential subject participated in the CAMPX trial and did not achieve complete closure.

Where it's running

• Detroit Foot and Ankle
  Clinton Township, Michigan, United States Recruiting

Study contacts

• Study coordinator: Bennett Sarver
• Email: info@serenagroups.com
• Phone: 1-833-865-6300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers

  This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.

  Recruiting BioLab Holdings · Philidelphia, Pennsylvania · NCT07364630

• Using human placental membrane wraps with regular wound care to help heal stubborn diabetic foot and venous leg ulcers

  This trial tests whether adding one of four human placental membrane wraps to standard wound care helps people with nonhealing diabetic foot or venous leg ulcers heal faster and more completely than standard care alone.

  Recruiting Phase 4 BioLab Holdings · Philidelphia, Pennsylvania · NCT07089602

• Wound matrix treatments for nonhealing diabetic foot ulcers

  This trial will test whether adding special wound matrix products to standard care helps close hard-to-heal diabetic foot ulcers in adults with type 1 or 2 diabetes within 12 weeks.

  Recruiting Phase 4 Sequence LifeScience, Inc. · Monroeville, Pennsylvania · NCT07086443

• Evaluating new treatments for nonhealing diabetic foot and venous leg ulcers.

  This study is testing whether new treatments for stubborn diabetic foot and leg ulcers can help people heal better when combined with standard care compared to just standard care alone.

  Recruiting Phase 4 Tiger Biosciences, LLC. · Monroeville, Pennsylvania · NCT06826339

• Using a special cast to heal diabetic foot ulcers

  This study tests whether a special soft cast can help heal diabetic foot ulcers better than regular methods.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT04210089

• BIOxHEAL plus standard care for nonhealing diabetic foot ulcers

  A multicenter study tests whether applying BIOxHEAL, a placental-derived biologic, to stubborn diabetic foot ulcers helps more people heal when added to standard wound care.

  Recruiting Phase 3 Applied Biologics, LLC · Boardman, Ohio · NCT07852338

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.